Alps Advisors Inc Maravai Lifesciences Holdings, Inc. Transaction History

Alps Advisors Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$12.09 - $15.0 $1,994 - $2,475	165 Added 0.77%	21,665 $269,000
Q1 2023 May 10, 2023	BUY	$12.99 - $16.48 $279,285 - $354,320	21,500 New	21,500 $301,000
Q2 2022 Aug 11, 2022	SELL	$26.05 - $37.48 $2,422 - $3,485	-93 Reduced 1.03%	8,978 $255,000
Q1 2022 May 16, 2022	BUY	$24.46 - $40.92 $27,688 - $46,321	1,132 Added 14.26%	9,071 $320,000
Q4 2021 Feb 09, 2022	BUY	$35.0 - $45.94 $5,530 - $7,258	158 Added 2.03%	7,939 $333,000

Q3 2021 Nov 15, 2021	BUY	$36.8 - $60.62 $286,340 - $471,684	7,781 New	7,781 $382,000

227

135M

339K

148K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $919M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.